Skip to Main Content

Pharmacokinetics and Hepatic Safety of EGCG

Conditions

Women's Health | Pregnancy, Childbirth and the Puerperium

Phase Pilot

What is the purpose of this trial?

A trial to assess the pharmacokinetics and hepatic safety of EGCG in women with and without uterine fibroids.

  • Trial with
    National Institutes of Health (NIH)
  • Start Date
    09/13/2021
  • End Date
    09/30/2021

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    11/04/2021
  • Study HIC
    #2000029129